FibroBiologics Inc. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Side Letter, dated December 19, 2024, by and among FibroBiologics, Inc., GEM Global Yield LLC SCS, and GEM Yield Bahamas Limited (Filed With SEC on December 20, 2024)
- Amendment 1 to the Intellectual Property Cross-License Agreement between SpinalCyte LLC and FibroBiologics, Inc., effective as of May 17, 2021 (Filed With SEC on August 7, 2024)
- Form of Placement Agent Agreement (Filed With SEC on June 4, 2024)
- Form of Placement Agent Agreement (Filed With SEC on April 26, 2024)
- Description of registrants securities (Filed With SEC on February 29, 2024)
- Engagement Letter between FibroBiologics, Inc. and Maxim Group LLC dated April 24, 2023 (Filed With SEC on January 22, 2024)
- Agreement Regarding Right of First Negotiation dated January 20, 2023 (Filed With SEC on November 28, 2023)
- IP Transfer Agreement between SpinalCyte, LLC and FibroBiologics, LLC, dated as of May 17, 2021 (Filed With SEC on November 28, 2023)
- Intellectual Property Cross-License Agreement dated as of May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 28, 2023)
- Agreement Regarding Right of First Negotiation dated January 20, 2023 (Filed With SEC on November 7, 2023)
- IP Transfer Agreement between SpinalCyte, LLC and FibroBiologics, LLC, dated as of May 17, 2021 (Filed With SEC on November 7, 2023)
- Intellectual Property Cross-License Agreement dated as of May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 7, 2023)
